Orthofix (NSDQ:OFIX) today said it fully launched its Oscar Pro ultrasonic arthroplasty revision system in the U.S. and Europe. The ultrasonic surgical system’s creators designed it to aid in the removal of cement during complex joint revision surgeries. Oscar Pro’s new design includes an enhanced user interface to enable a more efficient surgical experience and new […]
Haemonetics plummets on mixed-bag Q4 results
Haemonetics (NYSE:HAE) posted fourth-quarter results today that beat the revenue consensus on Wall Street and missed on earnings estimates. The company reported losses of -$11 million, or -22¢ per share, on sales of $225 million for the three months ended April 3, for a sales loss of -5.65% compared with Q4 2021. Adjusted to exclude one-time […]
BD enrolls first patients in arteriovenous endovascular fistula post-market trial
BD (NYSE: BDX) recently announced that it has begun enrollment for its post-market surveillance study of its WavelinQ arteriovenous endovascular fistula device. The Connect-AV trial is a prospective, single-arm, open-label study that will follow WavelinQ EndoAVF system patients for 24 months. Its dual primary effectiveness endpoints are the percentage of subjects dialyzing with successful 2-needle cannulation […]
Boston Scientific initiates coronary drug-coated balloon study in U.S.
Boston Scientific (NYSE:BSX) this week launched its Agent IDE trial for its Agent drug-coated balloon. The U.S. prospective, randomized clinical trial will evaluate the safety and effectiveness of a drug-coated balloon (DCB) in patients with coronary in-stent restenosis in lesions up to 26 mm in length in a coronary artery 2.0 mm to 4.0 mm in […]
Endologix launches Alto abdominal stent graft in Canada
Endologix (NSDQ:ELGX) today said it launched its Alto abdominal stent graft in Canada following its recent Health Canada approval. The Alto abdominal stent graft system is a polymer-based therapy for abdominal aortic aneurysm (AAA) patients. It uses a low-profile delivery system with a conformable sealing ring that molds in-situ to the patient’s specific aortic neck anatomy. […]
Shockwave Medical stock up nearly 21%
Shockwave Medical (NSDQ:SWAV) posted first-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. Shockwave Medical, though, also said it projects revenue for the full year to roughly triple to between $195–205 million — representing 188–202% growth over the prior year’s revenue. The Santa Clara, Calif.-based company — which has proprietary cardiovascular […]
ReWalk Robotics slides before hours on missed earnings in Q1
ReWalk Robotics (NSDQ:RWLK) posted first-quarter results today that beat the revenue consensus on Wall Street but missed on earnings estimates. The Marlborough, Mass.-based company reported losses of -$3.06 million, or -8¢ per share, on sales of $1.3 million for the three months ended March 31, for a sales growth of 73.16% compared with Q1 2020, […]
Transit Scientific scoring sheath wins CE mark
Transit Scientific today said it received CE mark clearance for its XO Score scoring sheath platform. XO Score is designed for dilation of stenotic material in the peripheral vasculature, including popliteal, infrapopliteal and native or synthetic arteriovenous dialysis fistulae. The scoring and cutting technology in the device enables low-pressure lesion dilation and vessel prep with […]
FDA clears Olympus airway mobilescopes
Olympus (TYO:7733) today said it received FDA clearance for its line of airway mobilescopes. The mobilescopes enable physicians to perform a broad range of upper and lower airway management procedures. “We are proud to present to the market the only flexible mobilescope models with a video camera on the tip,” said Lynn Ray, VP and GM […]
Axonics rises on mixed-bag Q1 results
Axonics (NSDQ:AXNX) posted first-quarter results that beat the revenue consensus on Wall Street but missed on earnings projections. The Irvine, Calif.-based company yesterday evening reported losses of –$22.5 million, or –57¢ per share, on sales of $34.4 million for the three months ended March 31 — versus a loss of –$14.6 million, or –43¢ per […]
Cardiovascular Systems sinks on missed Q3 earnings projections
Cardiovascular Systems (NSDQ:CSII) posted third-quarter results that beat the revenue consensus on Wall Street but missed on earnings projections. The St. Paul, Minn.-based company yesterday evening reported losses of –$6 million, or –15¢ per share, on sales of $63.27 million for the three months ended March 31, 2021 — versus a loss of nearly –$4 […]